Versant Voyageurs I, L.P., 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 8,675 shares at $33.31 ($293K) on 2020-11-13, disclosed to the SEC on 2020-11-17.
Scheduled sale ($293k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.31 | 327 | $11K | 3.7% |
| 2 | $33.31 | 2,473 | $82K | 28.1% |
| 3 | $33.31 | 2,473 | $82K | 28.1% |
| 4 | $34.53 | 198 | $7K | 2.3% |
| 5 | $34.53 | 1,502 | $52K | 17.7% |
| 6 | $34.53 | 1,502 |
| $52K |
| 17.7% |
| 7 | $33.01 | 23 | $759 | 0.3% |
| 8 | $33.01 | 177 | $6K | 2.0% |
| Total | $33.75 avg | 8,675 | $293K | 100% |
| Filing → |